BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29082410)

  • 1. Model system based proteomics to understand the host response during bacterial infections.
    Kamaladevi A; Marudhupandiyan S; Balamurugan K
    Mol Biosyst; 2017 Nov; 13(12):2489-2497. PubMed ID: 29082410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic view of the host-pathogen interaction: The host perspective.
    Hartlova A; Krocova Z; Cerveny L; Stulik J
    Proteomics; 2011 Aug; 11(15):3212-20. PubMed ID: 21726044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based proteomic approaches to study pathogenic bacteria-host interactions.
    Yang Y; Hu M; Yu K; Zeng X; Liu X
    Protein Cell; 2015 Apr; 6(4):265-74. PubMed ID: 25722051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis of host-pathogen interactions: Investigation of pathogen responses to the host cell environment.
    Schmidt F; Völker U
    Proteomics; 2011 Aug; 11(15):3203-11. PubMed ID: 21710565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of host-bacterial interactions: new insights from dual perspectives.
    Sukumaran A; Woroszchuk E; Ross T; Geddes-McAlister J
    Can J Microbiol; 2021 Mar; 67(3):213-225. PubMed ID: 33027598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of bacterial pathogenicity: therapeutic implications.
    Windle HJ; Brown PA; Kelleher DP
    Proteomics Clin Appl; 2010 Feb; 4(2):215-27. PubMed ID: 21137045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping in Touch with Type-III Secretion System Effectors: Mass Spectrometry-Based Proteomics to Study Effector-Host Protein-Protein Interactions.
    Meyer M; Ryck J; Goormachtig S; Van Damme P
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases.
    Jean Beltran PM; Federspiel JD; Sheng X; Cristea IM
    Mol Syst Biol; 2017 Mar; 13(3):922. PubMed ID: 28348067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arrays as tool for studies at the host-pathogen interface.
    Manzano-Román R; Dasilva N; Díez P; Díaz-Martín V; Pérez-Sánchez R; Orfao A; Fuentes M
    J Proteomics; 2013 Dec; 94():387-400. PubMed ID: 24140974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in the investigation of HIV-1 interactions with host proteins.
    Li M
    Proteomics Clin Appl; 2015 Feb; 9(1-2):221-34. PubMed ID: 25523935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the tick-pathogen interface by quantitative proteomics.
    Villar M; Popara M; Bonzón-Kulichenko E; Ayllón N; Vázquez J; de la Fuente J
    Ticks Tick Borne Dis; 2012 Jun; 3(3):154-8. PubMed ID: 22647712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic discovery of host kinase signaling in bacterial infections.
    Richter E; Mostertz J; Hochgräfe F
    Proteomics Clin Appl; 2016 Oct; 10(9-10):994-1010. PubMed ID: 27440122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity-Based Protein Profiling at the Host-Pathogen Interface.
    Kovalyova Y; Hatzios SK
    Curr Top Microbiol Immunol; 2019; 420():73-91. PubMed ID: 30203396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a Systems Biology Approach To Study Host-Pathogen Interactions.
    Yeung A; Hale C; Clare S; Palmer S; Bartholdson Scott J; Baker S; Dougan G
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics progresses in microbial physiology and clinical antimicrobial therapy.
    Chen B; Zhang D; Wang X; Ma W; Deng S; Zhang P; Zhu H; Xu N; Liang S
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):403-413. PubMed ID: 27812806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics characterization of tick-host-pathogen interactions.
    Popara M; Villar M; de la Fuente J
    Methods Mol Biol; 2015; 1247():513-27. PubMed ID: 25399117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.
    Coiras M; Camafeita E; López-Huertas MR; Calvo E; López JA; Alcamí J
    Proteomics; 2008 Feb; 8(4):852-73. PubMed ID: 18297655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-pathogen interactions: a proteomic view.
    Zhang CG; Chromy BA; McCutchen-Maloney SL
    Expert Rev Proteomics; 2005 Apr; 2(2):187-202. PubMed ID: 15892564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput proteomics and the fight against pathogens.
    Horvatić A; Kuleš J; Guillemin N; Galan A; Mrljak V; Bhide M
    Mol Biosyst; 2016 Jul; 12(8):2373-84. PubMed ID: 27227577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the proteomics of major arthropod vectors of human and animal pathogens.
    Patramool S; Choumet V; Surasombatpattana P; Sabatier L; Thomas F; Thongrungkiat S; Rabilloud T; Boulanger N; Biron DG; Missé D
    Proteomics; 2012 Dec; 12(23-24):3510-23. PubMed ID: 23077092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.